Bajaj Finserv Healthcare Growth Direct Plan
SIP amount
Min. ₹500
Lumpsum amount
Min. ₹500

Bajaj Finserv Healthcare Growth Direct Plan

NAV
₹8.7280
-1.27%
(27 Feb)
AUM
302 Cr
TER
0.61%
Risk
Very High Risk
Insights
Asset Under Management (AUM) is in the bottom 25% of comparable funds
Total Expense Ratio (TER) is in the bottom 25% of comparable funds
In beta. Send feedback here.
Compare with other fund
1Y
+3.2%
-2.5%
-4.4%
-6.7%
NA
3Y
+29.1%
+29.1%
+31.2%
+29.1%
NA
5Y
+29.2%
+24.4%
+23.2%
+22.3%
NA
ALL
+16.6%
+12.1%
+11.1%
+15.7%
-11.6%
VOL
18.2%
21.3%
20.4%
19.8%
16.3%
TER
1.1%
1.1%
0.8%
0.8%
0.6%
AUM
₹7,435 Cr
₹2,341 Cr
₹4,543 Cr
₹1,230 Cr
₹302 Cr
INFO
0.91
0.57
0.54
0.79
-0.71
See fund holdings as of 31st Jan
Top holdings
Divi's Laboratories Ltd
8.7%
Sun Pharmaceuticals Industries Ltd
8.7%
Dr Reddy's Laboratories Ltd
8.5%
Cipla Ltd
7.2%
Net Receivables / (Payables)
6.9%
Apollo Hospitals Enterprise Ltd
5.3%
Biocon Ltd
4.2%
Piramal Pharma Ltd
4.0%
Neuland Laboratories Limited
3.3%
Syngene International Ltd
3.3%
Top industry exposure
Healthcare
81.1%
Consumer Defensive
6.5%
Basic Materials
1.0%
Other information
Minimum SIP
₹500
Minimum lumpsum
₹500
Additional lumpsum
₹100
Portfolio turnover
-
Lock-in period
-
Exit load
No exit load
Fund objective
The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
Fund manager(s)
Nimesh Chandan
Siddharth Chaudhary
Sorbh Gupta

FAQs